Lanzoprazole
Phase 3Completed 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Heartburn
Conditions
Heartburn
Trial Timeline
Jun 1, 2006 → Jan 1, 2007
NCT ID
NCT00389948About Lanzoprazole
Lanzoprazole is a phase 3 stage product being developed by Novartis for Heartburn. The current trial status is completed. This product is registered under clinical trial identifier NCT00389948. Target conditions include Heartburn.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00389948 | Phase 3 | Completed |
Competing Products
20 competing products in Heartburn